Louis J. Picker

Active 1980–2026

135
Papers
37,537
Citations
91
h-index
131
i10-index

Citations

Citations per year for Louis J. Picker1979: 1 citations1981: 11 citations1982: 7 citations1983: 13 citations1984: 9 citations1985: 9 citations1986: 10 citations1987: 8 citations1988: 21 citations1989: 61 citations1990: 116 citations1991: 143 citations1992: 180 citations1993: 199 citations1994: 199 citations1995: 192 citations1996: 191 citations1997: 225 citations1998: 279 citations1999: 354 citations2000: 367 citations2001: 359 citations2002: 421 citations2003: 362 citations2004: 371 citations2005: 279 citations2006: 273 citations2007: 346 citations2008: 344 citations2009: 294 citations2010: 304 citations2011: 310 citations2012: 299 citations2013: 259 citations2014: 211 citations2015: 188 citations2016: 205 citations2017: 161 citations2018: 180 citations2019: 685 citations2020: 580 citations2021: 568 citations2022: 424 citations2023: 325 citations2024: 496 citations2025: 208 citations2026: 12 citations1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,701 citing papers, 40.5% of this breakdownUnited Kingdom: 900 citing papers, 7.7% of this breakdownGermany: 702 citing papers, 6% of this breakdownFrance: 476 citing papers, 4.1% of this breakdownCanada: 429 citing papers, 3.7% of this breakdownItaly: 382 citing papers, 3.3% of this breakdownChina: 369 citing papers, 3.2% of this breakdownNetherlands: 348 citing papers, 3% of this breakdownAustralia: 328 citing papers, 2.8% of this breakdownSwitzerland: 297 citing papers, 2.6% of this breakdownJapan: 272 citing papers, 2.3% of this breakdownSpain: 257 citing papers, 2.2% of this breakdown
0%40.5%Other 18.6%

Fields

  • Immunology and Microbiology43%
  • Medicine42.6%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Neuroscience1.4%
  • Agricultural and Biological Sciences0.5%
  • Nursing0.2%
  • Other1.2%

Topics

  • Immune Cell Function and Interaction10.3%
  • T-cell and B-cell Immunology8.9%
  • HIV Research and Treatment8.2%
  • Immunotherapy and Immune Responses5.6%
  • Cell Adhesion Molecules Research4.2%
  • Cytomegalovirus and herpesvirus research4%
  • Other58.8%

Coauthors

All papers

Open in search
  1. Microbial translocation is a cause of systemic immune activation in chronic HIV infection

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2006 cited by 3,542

  2. CD4+ T‐cell depletion in HIV infection: mechanisms of immunological failure

    Authors: , - Immunological Reviews 2013 cited by 577

  3. Broadly targeted human cytomegalovirus-specific CD4 + and CD8 + T cells dominate the memory compartments of exposed subjects

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 1,342

  4. Sequence diversity analyses of an improved rhesus macaque genome enhance its biomedical utility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudia Rita Catacchio, Jason G. Underwood, David H. O’Connor, Ashley D. Sanders, Jan O. Korbel, Betsy Ferguson, H. Michael Kubisch, Louis J. Picker, Ned H. Kalin, Douglas L. Rosene, Jon E. Levine, David H. Abbott, Stanton B. Gray, Mar M. Sánchez, Zsofia A. Kovacs-Balint, Joseph W. Kemnitz, Sara M. Thomasy, Jeffrey A. Roberts, Erin L. Kinnally, John P. Capitanio, J. H. Pate Skene, Michael L. Platt, Shelley A. Cole, Richard E. Green, Mario Ventura, Roger W. Wiseman, Benedict Paten, Mark A. Batzer, Jeffrey Rogers, Evan E. Eichler - Science 2020 cited by 200

  5. Changes in thymic function with age and during the treatment of HIV infection

    Authors: , , , , , , , , , , , , , - Nature 1998 cited by 1,904

  6. Immune clearance of highly pathogenic SIV infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2013 cited by 622

  7. Ultra-low Dose Aerosol Infection of Mice with Mycobacterium tuberculosis More Closely Models Human Tuberculosis

    Authors: , , , , , , , , , , , , , , , - Cell Host & Microbe 2020 cited by 138

  8. Lymphocyte Homing and Homeostasis

    Authors: , - Science 1996 cited by 2,874

  9. TGFβ restricts expansion, survival, and function of T cells within the tuberculous granuloma

    Authors: , , , , , , , , , , , , - Cell Host & Microbe 2021 cited by 90

  10. The Identity of Human Tissue-Emigrant CD8+ T Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ali Naji, David H. Canaday, Terri M. Laufer, Andrew D. Wells, David A. Price, Ian Frank, Daniel C. Douek, E. John Wherry, Maxim Itkin, Michael R. Betts - Cell 2020 cited by 108

  11. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2011 cited by 1,002

  12. Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Aderem, Galit Alter, Dominick J. Laddy, Michele Stone, Aurelio Bonavia, Thomas G. Evans, Michael K. Axthelm, Klaus Früh, Paul T. Edlefsen, Louis J. Picker - Nature Medicine 2018 cited by 266

  13. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 480

  14. Broadly targeted CD8 + T cell responses restricted by major histocompatibility complex E

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2016 cited by 293

  15. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

    Authors: , , , , , , , , , , , , , , - Nature Medicine 2009 cited by 673

  16. A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 112

  17. The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2019 cited by 102

  18. Myeloid cell tropism enables MHC-E–restricted CD8 + T cell priming and vaccine efficacy by the RhCMV/SIV vaccine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2022 cited by 40

  19. Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 84

  20. Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2021 cited by 60

  21. HLA-E–restricted, Gag-specific CD8 + T cells can suppress HIV-1 infection, offering vaccine opportunities

    Authors: , , , , , , , , , , , , , , , , , , - Science Immunology 2021 cited by 60

  22. Programming cytomegalovirus as an HIV vaccine

    Authors: , , , , - Trends in Immunology 2023 cited by 49

  23. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys

    Authors: , , , - Nature Medicine 2006 cited by 497

  24. Evasion of CD8 + T Cells Is Critical for Superinfection by Cytomegalovirus

    Authors: , , , , , , , , , , - Science 2010 cited by 266